Literature DB >> 16220113

St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways.

Solveigh Krusekopf1, Ivar Roots.   

Abstract

OBJECTIVES AND METHODS: The effects of St. John's wort and hyperforin on gene expression were analysed in HepG2 cells by Affymetrix microarray hybridization and real time reverse transcription-PCR.
RESULTS: Both compounds increased mRNAs of the drug metabolizing enzymes CYP3A4, CYP1A1, CYP1A2 and the flavin containing monooxygenase FMO5, and of the multidrug resistance protein MRP2. CYP4F2 and the reduced nicotinamide adenine dinucleotide dehydrogenase NQO1 were downregulated. Expression of genes mediating cholesterol biosynthesis was decreased, while facilitated glucose transporters and glycolysis genes were induced, indicating increased glucose metabolism. Changes of a considerable number of additional transcripts corresponded to reports on gene regulation by hypoxia. Endoplasmic reticulum stress-regulated genes involved in unfolded protein response and in protection of cells from apoptosis were downregulated. Other calcium binding proteins were affected by both treatments, suggesting an increase in intracellular calcium.
CONCLUSIONS: St. John's wort and hyperforin concordantly affected expression of genes not only mediating metabolism and transport of exogenous and endogenous compounds, but also involved in energy metabolism, intracellular calcium regulation, cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220113     DOI: 10.1097/01.fpc.0000175597.60066.3d

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  10 in total

1.  Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).

Authors:  Frank Holtrup; Andrea Bauer; Kurt Fellenberg; Ralf A Hilger; Michael Wink; Jörg D Hoheisel
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 2.  Drug transporters in pharmacokinetics.

Authors:  Ernst Petzinger; Joachim Geyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-11       Impact factor: 3.000

Review 3.  Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

Authors:  Adriana Albini; Stefano Indraccolo; Douglas M Noonan; Ulrich Pfeffer
Journal:  Clin Exp Metastasis       Date:  2010-04-10       Impact factor: 5.150

4.  Identification of JAK-STAT pathways as important for the anti-inflammatory activity of a Hypericum perforatum fraction and bioactive constituents in RAW 264.7 mouse macrophages.

Authors:  Kimberly D P Hammer; Man-Yu Yum; Philip M Dixon; Diane F Birt
Journal:  Phytochemistry       Date:  2010-03-18       Impact factor: 4.072

5.  Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach.

Authors:  Gurpreet K Grewal; Khuraijam D Singh; Neha Kanojia; Chitra Rawat; Samiksha Kukal; Ajay Jajodia; Anshika Singhal; Richa Misra; Selvaraman Nagamani; Karthikeyan Muthusamy; Ritushree Kukreti
Journal:  Pharm Res       Date:  2017-04-21       Impact factor: 4.200

6.  Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.

Authors:  Tong Zhang; Ping Yang; Jianchang Wei; Wanglin Li; Junbin Zhong; Huacui Chen; Jie Cao
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

7.  The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing.

Authors:  Sandra G Gonzalez Malagon; Anna N Melidoni; Diana Hernandez; Bilal A Omar; Lyndsey Houseman; Sunil Veeravalli; Flora Scott; Dorsa Varshavi; Jeremy Everett; Yugo Tsuchiya; John F Timms; Ian R Phillips; Elizabeth A Shephard
Journal:  Biochem Pharmacol       Date:  2015-06-04       Impact factor: 5.858

8.  Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut Bacteria.

Authors:  Flora Scott; Sandra G Gonzalez Malagon; Brett A O'Brien; Diede Fennema; Sunil Veeravalli; Clarissa R Coveney; Ian R Phillips; Elizabeth A Shephard
Journal:  Drug Metab Dispos       Date:  2017-06-23       Impact factor: 3.922

9.  Systems pharmacology uncovers Janus functions of botanical drugs: activation of host defense system and inhibition of influenza virus replication.

Authors:  Xia Wang; Xue Xu; Yan Li; Xiuxiu Li; Weiyang Tao; Bohui Li; Yonghua Wang; Ling Yang
Journal:  Integr Biol (Camb)       Date:  2013-02       Impact factor: 2.192

10.  Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.

Authors:  John K Darby; David J Pasta; Michael G Wilson; John Herbert
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.